BQURA

Ensol Biosciences Expands Licensing Agreement for Degenerative Disc Disease Treatment P2K

L&C Bio Secures Patent for Breast Reconstruction Skin Substitute and Manufacturing Method

ABL Bio Halts Development of Bispecific Antibody Immuno-Oncology Candidate ‘ABL501’ After Phase 1 Trial Results

SK Biopharm Aims for Success with Second Epilepsy Treatment, Initiates Domestic Clinical Trials

Following the successful launch of its independently developed epilepsy treatment, ‘Cenobamate’...

Idience's Venadaparib Research Published in AACR Journal 0'

Idience, a subsidiary of Il-Dong Pharmaceutical Group specializing in new drug development, ann...

Find out the latest information and data from Korean Biopharma companies